EcoR1 Capital, LLC — 13F Holdings

2026 Q3  ·  43 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, EcoR1 Capital, LLC maintained a portfolio of 43 distinct positions. The most significant new addition was BRISTOL-MYERS SQUIBB CO, now representing 9.70% of the total fund value. They heavily accumulated shares in CG ONCOLOGY INC, increasing the position by 233.4%. Conversely, EcoR1 Capital, LLC completely exited their position in CG ONCOLOGY INC.
Position History hover any row below to update
Loading…
EcoR1 Capital, LLC San Francisco, CA Hedge Fund AUM $2,034M
PCA Score Concentration Risk
Risk ENB
Total Positions
43
Quarter
2026 Q3
Top Holding
ZYME (27.0%)
Top 10 Concentration
83.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-43 of 43

EcoR1 Capital, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
ZYME
ZYMEWORKS INC
Healthcare 27.01% 29.19% #1
Prev: #1
7.0
—
no change no change
P
S
22,970,388 $608,485,578
$10.13 nan%
$26.49 nan%
2022 Q4 13F Filing 2026-09-30 2026-11-16
ANAB
ANAPTYSBIO INC
Healthcare 17.58% 25.86% #2
Prev: #2
6.5
—
no change no change
P
S
7,880,094 $396,053,524
$13.09 nan%
$50.26 nan%
2019 Q4 13F Filing 2026-09-30 2026-11-16
BMY
BRISTOL-MYERS S...
CALL
CALL Option 9.70% — #3
Prev: #—
8.4
—
3,500,000 —
NEW
3,500,000 $218,400,000
$61.65 +2.1%
$61.76 +1.9%
2016 Q4 13F Filing 2026-09-30 2026-11-16
CGON
CG ONCOLOGY INC
Healthcare 5.89% 5.16% #4
Prev: #4
5.4
—
377,592 25.3%
P
S
1,871,892 $132,698,424 2025 Q4 13F Filing 2026-09-30 2026-11-16
ETON
ETON PHARMACEUT...
Healthcare 5.65% 3.82% #5
Prev: #5
4.8
—
298,982 13.8%
P
S
2,470,920 $127,227,671 2024 Q3 13F Filing 2026-09-30 2026-11-16
TRAX
FIRST TRACKS BI...
Healthcare 4.99% 3.11% #6 2
Prev: #8
3.0
—
no change no change
P
S
3,174,519 $112,504,953 2026 Q2 13F Filing 2026-09-30 2026-11-16
AKTS
AKTIS ONCOLOGY ...
Healthcare 4.17% 7.56% #7 4
Prev: #3
2.7
—
no change no change
P
S
4,824,469 $93,932,411 2026 Q1 13F Filing 2026-09-30 2026-11-16
CRSP
CRISPR THERAPEU...
Healthcare 3.41% 3.68% #8 2
Prev: #6
2.4
—
no change no change
P
S
1,389,276 $76,854,748 2018 Q3 13F Filing 2026-09-30 2026-11-16
ANRO
ALTO NEUROSCIEN...
Healthcare 2.53% — #9
Prev: #—
4.5
—
2,232,000 —
NEW
2,232,000 $56,982,960 2026 Q3 13F Filing 2026-09-30 2026-11-16
GLPG
LAKEFRONT BIOTH...
Healthcare 2.19% 2.43% #10 1
Prev: #9
1.9
—
no change no change
P
S
1,667,119 $49,430,078 2015 Q4 13F Filing 2026-09-30 2026-11-16
ERAS
ERASCA INC
Healthcare 1.92% 0.29% #11 16
Prev: #27
3.8
—
2,620,000 793.9%
P
S
2,950,000 $43,247,000 2021 Q3 13F Filing 2026-09-30 2026-11-16
ORIC
ORIC PHARMACEUT...
Healthcare 1.81% 3.54% #12 5
Prev: #7
0.7
—
-3,700,000 -55.0%
P
S
3,028,116 $40,788,723 2020 Q2 13F Filing 2026-09-30 2026-11-16
NGNE
NEUROGENE INC
Healthcare 1.57% 1.94% #13 3
Prev: #10
1.6
—
no change no change
P
S
1,271,342 $35,368,734 2023 Q4 13F Filing 2026-09-30 2026-11-16
N/A
ATTOVIA THERAPE...
Unknown 1.54% — #14
Prev: #—
4.1
—
2,024,010 —
NEW
2,024,010 $34,691,531 — 13F Filing 2026-09-30 2026-11-16
FULC
FULCRUM THERAPE...
Healthcare 1.12% 1.17% #15 2
Prev: #13
0.9
—
253,919 3.9%
P
S
6,803,785 $25,174,005 2020 Q2 13F Filing 2026-09-30 2026-11-16
ADRX
ADARX PHARMACEU...
Healthcare 1.02% — #16
Prev: #—
3.9
—
1,150,000 —
NEW
1,150,000 $22,931,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
STOK
STOKE THERAPEUT...
Healthcare 0.96% 1.17% #17 5
Prev: #12
2.4
—
100,000 13.6%
P
S
835,000 $21,710,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
ZBIO
ZENAS BIOPHARMA...
Healthcare 0.95% 0.97% #18 1
Prev: #17
1.4
—
no change no change
P
S
789,500 $21,292,815 2025 Q4 13F Filing 2026-09-30 2026-11-16
ETRA
ELECTRA THERAPE...
Healthcare 0.85% — #19
Prev: #—
3.8
—
1,700,000 —
NEW
1,700,000 $19,125,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
ATRA
ATARA BIOTHERAP...
Healthcare 0.59% 0.87% #20 2
Prev: #18
1.2
—
no change no change
P
S
1,552,000 $13,192,000 2024 Q2 13F Filing 2026-09-30 2026-11-16
CAPR
CAPRICOR THERAP...
Healthcare 0.58% — #21
Prev: #—
3.7
—
1,376,580 —
NEW
1,376,580 $13,036,213 2026 Q3 13F Filing 2026-09-30 2026-11-16
XNCR
XENCOR INC
Healthcare 0.55% — #22
Prev: #—
3.7
—
500,000 —
NEW
500,000 $12,475,000 2016 Q2 13F Filing 2026-09-30 2026-11-16
ODTX
ODYSSEY THERAPE...
Healthcare 0.55% 0.51% #23 2
Prev: #21
1.2
—
no change no change
P
S
555,555 $12,344,432 2026 Q2 13F Filing 2026-09-30 2026-11-16
AURA
AURA BIOSCIENCE...
Healthcare 0.46% 0.58% #24 4
Prev: #20
1.2
—
no change no change
P
S
1,666,667 $10,466,669 2026 Q2 13F Filing 2026-09-30 2026-11-16
NRIX
NURIX THERAPEUT...
Healthcare 0.39% 0.32% #25 1
Prev: #26
2.7
—
105,000 38.9%
P
S
375,000 $8,891,250 2020 Q3 13F Filing 2026-09-30 2026-11-16
BRVE
BRAVEHEART BIO ...
Healthcare 0.37% — #26
Prev: #—
3.6
—
416,700 —
NEW
416,700 $8,417,340 2026 Q3 13F Filing 2026-09-30 2026-11-16
PHVS
PHARVARIS N V
Healthcare 0.33% 0.40% #27 4
Prev: #23
1.1
—
no change no change
P
S
235,000 $7,454,200 2023 Q4 13F Filing 2026-09-30 2026-11-16
EIKN
EIKON THERAPEUT...
Healthcare 0.31% 0.46% #28 6
Prev: #22
2.1
—
123,028 16.8%
P
S
855,634 $6,879,297 2026 Q1 13F Filing 2026-09-30 2026-11-16
ELOX
ELOXX PHARMACEU...
Healthcare 0.27% 0.27% #29 1
Prev: #28
1.1
—
no change no change
P
S
400,000 $6,124,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
AARD
AARDVARK THERAP...
Healthcare 0.17% 0.11% #30 1
Prev: #29
3.1
—
323,834 81.7%
P
S
720,028 $3,794,548 2026 Q2 13F Filing 2026-09-30 2026-11-16
BBOT
BRIDGEBIO ONCOL...
Healthcare 0.16% 1.05% #31 16
Prev: #15
0.1
—
-1,933,519 -68.5%
P
S
889,607 $3,647,389 2025 Q3 13F Filing 2026-09-30 2026-11-16
N/A
TCGX ACQUISITIO...
Unknown 0.14% — #32
Prev: #—
3.6
—
250,000 —
NEW
250,000 $3,127,500 — 13F Filing 2026-09-30 2026-11-16
ZURA
ZURA BIO LTD
Healthcare 0.13% 0.34% #33 9
Prev: #24
0.1
—
-500,000 -42.4%
P
S
679,715 $2,827,614 2026 Q1 13F Filing 2026-09-30 2026-11-16
N/A
HELIX ACQUISITI...
Unknown 0.09% 0.10% #34 4
Prev: #30
1.0
—
no change no change
P
S
200,000 $2,124,000 — 13F Filing 2026-09-30 2026-11-16
CTNM
CONTINEUM THERA...
Healthcare 0.04% — #35
Prev: #—
3.5
—
64,303 —
NEW
64,303 $862,946 2026 Q3 13F Filing 2026-09-30 2026-11-16
CGON
CG ONCOLOGY INC
CALL
CALL Option 0.00% 1.94% #36 25
Prev: #11
0.0
—
-561,400 -100.0%
P
S
100 $7,089 2025 Q4 13F Filing 2026-09-30 2026-11-16
AARD
AARDVARK THERAP...
CALL
CALL Option 0.00% 0.00%
Sold All 😨
(Was: #33)
0.0
—
-14,700 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
SRZNW
SURROZEN INC
Unknown 0.00% 0.01%
Sold All 😨
(Was: #32)
0.0
—
-4,444 -100.0%
CLOSED
— $— 2021 Q3 13F Filing 2026-09-30 2026-11-16
MREO
MEREO BIOPHARMA...
Healthcare 0.00% 0.02%
Sold All 😨
(Was: #31)
0.0
—
-1,000,000 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
PHAT
PHATHOM PHARMAC...
Healthcare 0.00% 0.33%
Sold All 😨
(Was: #25)
0.0
—
-625,000 -100.0%
CLOSED
— $— 2023 Q2 13F Filing 2026-09-30 2026-11-16
RLAY
RELAY THERAPEUT...
Healthcare 0.00% 0.63%
Sold All 😨
(Was: #19)
0.0
—
-697,948 -100.0%
CLOSED
— $— 2020 Q3 13F Filing 2026-09-30 2026-11-16
MBX
MBX BIOSCIENCES...
Healthcare 0.00% 1.04%
Sold All 😨
(Was: #16)
0.0
—
-388,500 -100.0%
CLOSED
— $— 2024 Q3 13F Filing 2026-09-30 2026-11-16
LEGN
LEGEND BIOTECH ...
Healthcare 0.00% 1.12%
Sold All 😨
(Was: #14)
0.0
—
-800,000 -100.0%
CLOSED
— $— 2021 Q4 13F Filing 2026-09-30 2026-11-16
Showing 1-43 of 43 holdings

Unlock Full EcoR1 Capital, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →